While currently approved therapies for COVID-19 like Paxlovid target a critical coronavirus protein known as Mpro, WEHI researchers identified another protein, termed PLpro, as a promising drug ...

Today’s opportunity comes within the retail sector, as a specific name has gone down to low prices not seen since the onset of the COVID-19 pandemic ... in shares of Target, some Wall Street ...

It doesn't help when one of the ETF's most recognizable holdings is down more than 10%. Target Corp (NYSE:TGT) stock is down 11.6% to trade at $93.92, and earlier fell to a five-year low of $93.26.